Global Human Milk Oligosaccharides in Infant Formula Sales Market Report 2021

0
4

Human Milk Oligosaccharides (HMOs) are the 3rd most abundant solid component of breast milk after fat and carbohydrates. They feed beneficial bacteria in the gut, where 70% of the immune system exists.

Market Analysis and Insights: Global Human Milk Oligosaccharides in Infant Formula Market
The global Human Milk Oligosaccharides in Infant Formula market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Human Milk Oligosaccharides in Infant Formula Scope and Market Size
The global Human Milk Oligosaccharides in Infant Formula market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Milk Oligosaccharides in Infant Formula market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
2?FL
3?FL
3?SL
6?SL

Segment by Application
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Other

The Human Milk Oligosaccharides in Infant Formula market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Milk Oligosaccharides in Infant Formula market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Abbott
BASF
Dextra Laboratories
DuPont
Elicityl
Glycom
Glycosyn
Inbiose
Jennewein Biotechnologie
Nestle Health Science
Zuchem

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.